Antimalarial synergy of cysteine and aspartic protease inhibitors.
about
Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparumSmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoniBlocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial proteaseEsterase mutation is a mechanism of resistance to antimalarial compoundsAntimalarial activity of azadipeptide nitrilesA Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineAdditive in vitro antiplasmodial effect of N-alkyl and N-benzyl-1,10-phenanthroline derivatives and cysteine protease inhibitor e64.Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatinSynergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasitesIdentification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug developmentGene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparumAnalysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.Identification of the protease inhibitor miraziridine A in the Red sea sponge Theonella swinhoei.Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence.Antimalarial activity of thiosemicarbazones and purine derived nitriles.Inactivation of Plasmepsin 2 and 3 sensitizes Plasmodium falciparum to the antimalarial drug piperaquine.Cysteine proteases in protozoan parasites
P2860
Q27973776-E8403E3D-55DC-45FA-81BF-69046E35F8F5Q28475558-AA36A4C0-8D57-4497-AB82-A0EB883A872AQ28536452-979A2965-C33D-470F-91B2-6FBC021D64B5Q28914748-96C99CD8-653F-40B7-9CE9-82D3AA84CCADQ30043987-0BEDCF83-2F5A-4B83-983D-DA9D6AF5D8D9Q33637348-65B22285-7C08-4B8F-981E-1DF4428589BCQ33654512-DD2B730D-B3E9-4155-8DFC-27D985A2AB38Q34158257-00780959-7F96-4131-B04B-8A3A3EABC89AQ34680640-6B1657A7-76F0-46A0-A8B3-6CC0CA6D1DFDQ35636034-9CA233D3-3094-4F55-A518-6EF16D7F132EQ35660425-5580F893-DA39-4EF3-A8C6-E9570AA59659Q36450822-F0CC8E12-7540-4840-A40D-947DD260FDC1Q36643383-E0160EE7-D5F4-4F92-8A5C-8081D1625586Q37357541-28212AAC-961E-4C02-BE14-C9C753CC0D1FQ39478859-9A7A1257-6B6E-4A02-9881-E90A4EAA5DBAQ40116314-2433CB84-5E5A-419B-9749-D847EBE3C224Q41474672-F33A073D-260B-4455-A475-3C15B2A35B12Q41938383-2D2478CE-6A68-43DA-9FE1-C00118911CDEQ50028083-D1BD9408-EE3B-412D-B13A-04DBA3F5C736Q58716061-E15F3F19-BFB4-4F7D-B516-367711276060
P2860
Antimalarial synergy of cysteine and aspartic protease inhibitors.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@ast
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@en
type
label
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@ast
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@en
prefLabel
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@ast
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@en
P2093
P2860
P1476
Antimalarial synergy of cysteine and aspartic protease inhibitors.
@en
P2093
P2860
P304
P407
P577
1998-09-01T00:00:00Z